Why Is AngioDynamics ($ANGO) Stock Down -21.85% Today? (Find out why any stock moved today on Tickeron.) Shares plunged roughly 21.85% in Wednesday's session, sliding from a prior close of $14.19 to around $11.09. Primary catalyst: The company's fiscal Q1 2027 earnings release, which beat headline estimates but failed to ease concerns about profitability and growth quality. Secondary driver: An unexpected leadership change, with longtime CEO Jim Clemmer retiring and Eric Honroth set to take over effective November 2. Guidance in focus: Management reiterated an adjusted full-year loss outlook and projected flat sales in its legacy Med Device segment. $STRRP $BLCO $MXCT $ICUI
published
Why Is AngioDynamics ($ANGO) Stock Down -21.85% Today? (Find out why any stock moved today on Tickeron.) Shares plunged roughly 21.85% in Wednesday's session, sliding from a prior close of $14.19 to around $11.09. Primary catalyst: The company's fiscal Q1 2027
$ANGO$STRRP$BLCO$MXCT$ICUI
Latest documented BWB result
See Billy's timestamped results and follow-through.
Review the latest gains posts, original timestamps, and proof images published by Banking With Billy.
Historical results are not a promise of future performance. Trading involves substantial risk.This public post is a timestamped information archive, not personalized financial advice. Alerts can change as markets move. Join Billy's private group for the complete daily stream and follow-through.